Stock data
bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc. (BIAF) reported revenue of US$6.16M and net income of -US$14.91M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$6.16M | — | -US$10.57M | -US$14.91M | — |
| 2024 | US$9.36M | — | -US$8.95M | -US$9.04M | — |
| 2023 | US$2.53M | — | -US$7.97M | -US$7.94M | — |
| 2022 | US$0.00M | US$0.00M | -US$4.01M | -US$8.15M | — |
| 2021 | — | — | -US$2.21M | -US$6.33M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.51M | -US$3.37M | — |
| 2026-03-31 | US$1.35M | -US$3.63M | — |
| 2025-12-31 | US$1.59M | -US$3.14M | — |
| 2025-09-30 | US$1.45M | -US$5.05M | — |
| 2025-06-30 | US$1.27M | -US$4.06M | — |
| 2025-03-31 | US$1.85M | -US$2.66M | — |
| 2024-12-31 | US$2.21M | -US$2.97M | — |
| 2024-09-30 | US$2.35M | -US$2.00M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.